Serologic evaluation of patients receiving procainamide.
about
Are there environmental forms of systemic autoimmune diseases?Drug-induced lupus erythematosus: incidence, management and prevention.Role of genetic factors in drug-related autoimmunity.Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.Effect of procainamide and hydralazine on poly (ADP-ribosylation) in cell lines.Triplex-DNA stabilization by hydralazine and the presence of anti-(triplex DNA) antibodies in patients treated with hydralazine.Hydralazine induces Z-DNA conformation in a polynucleotide and elicits anti(Z-DNA) antibodies in treated patients.Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation.
P2860
Q33741176-94C04AD6-4331-4C91-AA72-4AF4F1661430Q37868002-6DB57881-4C57-4CE3-A97A-826AD4384FA5Q40498816-E615D723-C349-49EE-82DF-20629DD224EEQ40569388-D5BD7953-935A-4768-A6F0-F814C5F73DC0Q41551927-E4E4C867-F158-4AC6-A2F6-10559F9901E9Q41670312-9C979842-B442-4E79-B751-B9698F5A839FQ41875776-535B478E-A538-4DDC-829C-37A67F2E6BB8Q47685778-AE76328F-E285-4455-A437-4DD7736EB447
P2860
Serologic evaluation of patients receiving procainamide.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Serologic evaluation of patients receiving procainamide.
@en
Serologic evaluation of patients receiving procainamide.
@nl
type
label
Serologic evaluation of patients receiving procainamide.
@en
Serologic evaluation of patients receiving procainamide.
@nl
prefLabel
Serologic evaluation of patients receiving procainamide.
@en
Serologic evaluation of patients receiving procainamide.
@nl
P2093
P356
P1476
Serologic evaluation of patients receiving procainamide.
@en
P2093
P304
P356
10.1002/ART.1780350216
P577
1992-02-01T00:00:00Z